These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 26610745

  • 1. TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
    Olivier CB, Weik P, Meyer M, Weber S, Anto-Michel N, Diehl P, Zhou Q, Geisen U, Bode C, Moser M.
    Thromb Res; 2016 Feb; 138():63-68. PubMed ID: 26610745
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors.
    Olivier CB, Weik P, Meyer M, Weber S, Diehl P, Bode C, Moser M, Zhou Q.
    J Thromb Thrombolysis; 2016 Aug; 42(2):161-6. PubMed ID: 26961375
    [Abstract] [Full Text] [Related]

  • 3. Enhanced TRAP-induced platelet aggregation with dabigatran - Clinical perspective.
    Bhagirath VC, Bosch J, Eikelboom JW.
    Thromb Res; 2016 Feb; 138():61-62. PubMed ID: 26757599
    [No Abstract] [Full Text] [Related]

  • 4. Thrombin Receptor Agonist Peptide-Induced Platelet Aggregation Is Reduced in Patients Receiving Dabigatran.
    Nehaj F, Sokol J, Mokan M, Ivankova J, Mokan M.
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):268-272. PubMed ID: 28703014
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation.
    Sokol J, Nehaj F, Ivankova J, Mokan M, Mokan M.
    J Thromb Thrombolysis; 2018 Oct; 46(3):393-398. PubMed ID: 30039454
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.
    Nehaj F, Sokol J, Ivankova J, Mokan M, Kovar F, Stasko J, Mokan M.
    Clin Appl Thromb Hemost; 2018 Sep; 24(6):914-919. PubMed ID: 29050502
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation.
    Semeraro F, Incampo F, Ammollo CT, Dellanoce C, Paoletti O, Testa S, Colucci M.
    Thromb Res; 2016 Feb; 138():22-29. PubMed ID: 26826504
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological Difference Between Platelet Aggregations in Cardioembolic Stroke Patients with Direct Oral Anticoagulants: A Pilot Study.
    Nakazaki M, Oka S, Magota H, Kiyose R, Onodera R, Ukai R, Kataoka-Sasaki Y, Sasaki M, Honmou O.
    J Stroke Cerebrovasc Dis; 2022 Jul; 31(7):106520. PubMed ID: 35523052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.
    Reers S, Agdirlioglu T, Kellner M, Borowski M, Thiele H, Waltenberger J, Reppel M.
    Eur J Med Res; 2016 Oct 21; 21(1):41. PubMed ID: 27769294
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.